Type
1.
Pierneef. Factors influencing the mental wellbeing of persons affected by leprosy in Sudurpashchim Pradesh, Nepal. 2019.
Type
1.
Paula H, Souza C, Silva S, Martins-Filho P, Barreto J, Gurgel R, et al. Risk Factors for Physical Disability in Patients With Leprosy: A Systematic Review and Meta-analysis. JAMA dermatology [Internet]. 2019;. Available from: https://jamanetwork.com/journals/jamadermatology/fullarticle/2739476?guestAccessKey=8c952de7-c202-4335-af5b-80dd28b6d7c8&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamadermatology&utm_content=etoc&utm_term=100919
Type
1.
Fiorati RC, Carretta RD, Joaquim KP, Placeres AF, Jesus TS. Anticipated Barriers to Implementation of Community-Based Rehabilitation in Ribeirão Preto, Brazil. Disability, CBR and Inclusive Development [Internet]. 2018;29(1):5-25. Available from: http://dcidj.org/article/download/701/384
Type
1.
Spanje. Cross-cultural validation of the Internalized Scale of Mental Illness (ISMI) in leprosy-affected people and people with disabilites in Nepal. Vrije Universiteit Amsterdam. 2012. p. 45.
Type
1.
Ramasamy S, Kumar A, Govindharaj P. Screening household contacts of children diagnosed with leprosy in a tertiary referral centre, Chhattisgarh State, India. Leprosy review [Internet]. 2018;89(2):117–123. Available from: https://leprosyreview.org/article/89/2/11-7123
Type
1.
Abubakar, Habib, Mathew. Amputation and disability following snakebite in Nigeria. Tropical doctor. 2010;40(2):114-6.
Type
1.
Mactaggart I, Schmidt W-P, Bostoen K, Chunga J, Danquah L, Halder AK, et al. Access to water and sanitation among people with disabilities: results from cross-sectional surveys in Bangladesh, Cameroon, India and Malawi. BMJ open [Internet]. 2018;8(6):e020077. Available from: http://bmjopen.bmj.com/content/bmjopen/8/6/e020077.full.pdf
Type
1.
Middag M. Perceived impact of a CBR programme: Impact evaluation of a CBR programme with the most significant change technique. Vrije Universiteit Amsterdam. 2013. p. 53.
Type
1.
Fischer J. Validation of a cross-NTD toolkit for assessment and monitoring of NTD-related morbidity and disability. 2016. p. 69.
Type
1.
Yakasai AM. Disability and impairment following snakebite in Africa. In: Clinical Toxinology in Asia Pacific and Africa. Dordrecht: Springer Netherlands; 2015. pp. 311-26.